6 February 2018
An upcoming GBI Research report has identified CD47 as a very important drug target in the future of breast cancer treatment.
12 January 2018
In 2018, we can expect to see large numbers of CRISPR trials taking off all over the world and we should not be afraid of this technology, because we severely...
27 October 2017
Hereditary retinal disorders are a result of genetic defects, and there are no approved treatments for most of these conditions.
17 October 2017
Scientists at the University of California, Berkeley, have engineered a new way to deliver CRISPR gene-editing technology inside cells, and have demonstrated in mice that it can repair the faulty...
11 August 2017
At present, a patient’s treatment for a disorder is not specifically matched to them, and is the same for everyone else with that condition.
1 August 2017
With the development of less expensive, advanced technologies for sequencing DNA and locating gene mutations and polymorphisms relevant to drug response, there has been greater incorporation of precision medicine protocols...
27 July 2017
Alzheimer’s disease (AD) is the most common form of dementia, an age-related neurodegenerative condition affecting 46.8 million people worldwide.
30 June 2017
A laid-back approach to sun protection and increased ultraviolet (UV) exposure is driving the rise of skin cancer prevalence worldwide, with the number of melanoma cases rising faster than any...
7 June 2017
Tempered optimism for early IDO + PD1 dual checkpoint blockade data in advanced urothelial carcinoma
Preliminary results were presented at the ASCO 2017 meeting for the Phase I/II ECHO-202/KEYNOTE-037 trial, investigating Incyte’s IDO inhibitor, epacadostat, in combination with Merck & Co’s PD-1 inhibitor, Keytruda, in...
25 May 2017
Age-related macular degeneration (AMD) has been earmarked as a priority eye disease by the World Health Organization, as the third-ranked cause of blindness globally.